Variables | Â | n (%) or median (range) |
---|---|---|
Male: Female | Â | 28 (61%)/18 (39%) |
Age, years | Â | 68.5 (39-84) |
ECOG-PS | 0 | 39 (85%) |
 | 1 | 7 (15%) |
Primary disease | Extrahepatic | 19 (41%) |
 | Intrahepatic | 8 (17%) |
 | Gallbladder | 10 (22%) |
 | Ampulla of Vater | 9 (20%) |
Pathologically stage (UICC) | I | 10 (22%) |
 | II | 29 (63%) |
 | III | 7 (15%) |
Surgical procedure | Pancreatoduodenectomy | 25 (54%) |
 | Hepatectomy (without bile duct resection) | 6 (13%) |
 | Hepatectomy (with bile duct resection) | 6 (13%) |
 | Extended cholecystectomy | 9 (20%) |
Morbidity (Clavien-Dindo ≥3) | Total | 10 (22%) |
 | Pancreatic fistula | 8 (17%) |
 | Liver abcess | 1 (2%) |
 | Intraabdominal abcess | 1 (2%) |
Residual tumor | 0 | 43 (94%) |
 | 1 | 3 (7%) |
Lymph node metastasis | Positive | 20 (46%) |
CEA, ng/dL | Â | 1.8 (0.1-54.0) |
CA19–9, ng/dL |  | 17.0 (1.0-3197) |